A detailed history of Fsa Wealth Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fsa Wealth Management LLC holds 25 shares of REGN stock, worth $17,546. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25
Previous 5 400.0%
Holding current value
$17,546
Previous $4,000 550.0%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $20,481 - $24,035
20 Added 400.0%
25 $26,000
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $3,875 - $4,408
5 New
5 $4,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Fsa Wealth Management LLC Portfolio

Follow Fsa Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fsa Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fsa Wealth Management LLC with notifications on news.